133 related articles for article (PubMed ID: 12558622)
1. Complete remission of metastatic clear cell sarcoma with DAV chemotherapy.
Fujimoto M; Hiraga M; Kiyosawa T; Murakami T; Murata S; Ohtsuki M; Nakagawa H
Clin Exp Dermatol; 2003 Jan; 28(1):22-4. PubMed ID: 12558622
[TBL] [Abstract][Full Text] [Related]
2. The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma.
Nagatani T; Ichiyama S; Onuma R; Miyazawa M; Matsuzaki T; Miyagawa K; Baba N; Uchiyama M; Nakajima H
Acta Derm Venereol; 1995 Nov; 75(6):494. PubMed ID: 8651034
[No Abstract] [Full Text] [Related]
3. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
[TBL] [Abstract][Full Text] [Related]
4. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
Maeda K; Miura S; Kawamura M; Jimbow K
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of malignant melanoma].
Ishihara K; Yamazaki N; Asano K
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
[TBL] [Abstract][Full Text] [Related]
6. [A case report of anorectal malignant melanoma showing a complete response after DTIC/ACNU/VCR therapy].
Sasaki S; Kojima T; Hidemura A; Hatanaka K; Uekusa T; Ishimaru M
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1999-2002. PubMed ID: 20948273
[TBL] [Abstract][Full Text] [Related]
7. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy].
Jimbow K; Takahashi H; Ishihara K; Hayasaka K; Kukita A; Seki Y; Ikeda S; Terakado T
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1942-9. PubMed ID: 7184382
[TBL] [Abstract][Full Text] [Related]
8. Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy.
Matsutani T; Onda M; Miyashita M; Hagiwara N; Akiya Y; Takubo K; Yamashita K; Sasajima K
Dis Esophagus; 2001; 14(3-4):241-4. PubMed ID: 11869329
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of malignant melanoma].
Ishihara K
Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
[TBL] [Abstract][Full Text] [Related]
10. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy (part II)].
Ishihara K; Hayasaka K; Ikeda S; Terakado T; Kukita A; Seki Y; Jimbow K; Suzuki M
Gan To Kagaku Ryoho; 1984 Mar; 11(3):467-73. PubMed ID: 6703721
[TBL] [Abstract][Full Text] [Related]
11. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
Tamura T; Miyamoto H; Harada M; Makinoya T; Yamamoto M; Miyoshi Y; Komi N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine.
Kageshita T; Kuribayashi N; Ono T
J Dermatol; 2000 Mar; 27(3):178-80. PubMed ID: 10774145
[TBL] [Abstract][Full Text] [Related]
13. [New combination chemotherapy for malignant melanoma--PAV(peplomycin, ACNU, VCR) therapy].
Ikeda S; Tajima K; Miyasato H; Terakado T; Suzuki T; Miura T
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2198-204. PubMed ID: 6194756
[TBL] [Abstract][Full Text] [Related]
14. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T
Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724
[No Abstract] [Full Text] [Related]
15. Gastroduodenal metastases in a clear cell sarcoma patient.
Atalay C; Irkkan C; Pak I; Altinok M
J Exp Clin Cancer Res; 2003 Mar; 22(1):147-50. PubMed ID: 12725335
[TBL] [Abstract][Full Text] [Related]
16. Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma.
Yamazaki N; Yamamoto A; Wada T; Ishikawa M
J Dermatol; 1999 Aug; 26(8):489-93. PubMed ID: 10487002
[TBL] [Abstract][Full Text] [Related]
17. Concurrent chemoimmunotherapy in metastatic clear cell sarcoma: a case report.
Lauro S; Bordin F; Trasatti L; Lanzetta G; Della Rocca C; Frati L
Tumori; 1999; 85(6):512-4. PubMed ID: 10774576
[TBL] [Abstract][Full Text] [Related]
18. Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma.
Nitta Y; Ikeya T; Sakakibara A; Tomita Y
J Dermatol; 2011 Feb; 38(2):164-8. PubMed ID: 21269313
[TBL] [Abstract][Full Text] [Related]
19. [Metastatic malignant melanoma of the urinary bladder: a case report].
Nohara T; Sakai A; Fuse H; Imamura Y
Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):707-11. PubMed ID: 19999137
[TBL] [Abstract][Full Text] [Related]
20. Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.
Suzuki Y; Aoyama N; Minamide J; Takata K; Ogata T
Int J Clin Oncol; 2005 Jun; 10(3):204-7. PubMed ID: 15990972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
